authors Sabbagh, Marwan N Quinn, Joseph F Taylor, Angela Galasko, Douglas Galvin, James E Goldman, Jennifer G Leverenz, James B Poston, Kathleen L Boeve, Bradley F Irwin, David J
Keywords clinical trials dementia with Lewy bodies drug development outcome measures regulatory pathways